✦ LIBER ✦

Chemotherapy in hormone-refractory prostate cancer

✍ Scribed by Ronald De Wit

Book ID: 109053811
Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 114 KB
Volume: 101
Category: Article
ISSN: 1464-4096
DOI: 10.1111/j.1464-410x.2007.07485.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Chemotherapy for hormone-refractory pros

Chemotherapy for hormone-refractory prostate cancer: Beauty is in the eye of the beholder

✍ Tomasz Beer; Derek Raghavan 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 143 KB 👁 2 views

Impact of PSA flare-up in patients with

Impact of PSA flare-up in patients with hormone-refractory prostate cancer undergoing chemotherapy

✍ Thomas Nelius; Tobias Klatte; Werner de Riese; Stephanie Filleur 📂 Article 📅 2007 🏛 Springer Netherlands 🌐 English ⚖ 206 KB

Combination chemotherapy with weekly doc

Combination chemotherapy with weekly docetaxel and estramustine for hormone refractory prostate cancer in Japanese patients

✍ Atsushi Takenaka; Yuji Yamada; Toshifumi Kurahashi; Hideo Soga; Hideaki Miyake; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB

Is there a role for platinum chemotherap

Is there a role for platinum chemotherapy in the treatment of patients with hormone-refractory prostate cancer?

✍ William K. Oh; Miah-Hiang Tay; Jiaoti Huang 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 153 KB 👁 3 views

Docetaxel-based chemotherapy with zoledr

Docetaxel-based chemotherapy with zoledronic acid and prednisone in hormone refractory prostate cancer: Factors predicting response and survival

✍ Rishi Nayyar; Nitin Sharma; Narmada P Gupta 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 168 KB

First- and second-line chemotherapy with

First- and second-line chemotherapy with docetaxel or mitoxantrone in patients with hormone-refractory prostate cancer : Does sequence matter?

✍ Jorg Michels; Trina Montemurro; Nevin Murray; Christian Kollmannsberger; Kim Ngu 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB 👁 1 views